-
公开(公告)号:US20200000762A1
公开(公告)日:2020-01-02
申请号:US16480773
申请日:2018-01-25
发明人: Stephen PERRETT
IPC分类号: A61K31/25 , C07C323/60 , A61K31/573
摘要: Described herein are prodrugs of cysteamine and pharmaceutically acceptable salts, solvates, and esters thereof. Also described herein are pharmaceutical compositions comprising prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates, and esters thereof, and methods of treatment comprising administering prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates, and esters thereof.
-
公开(公告)号:US20170071855A1
公开(公告)日:2017-03-16
申请号:US15205390
申请日:2016-07-08
CPC分类号: A61K9/0065 , A61K9/0053 , A61K9/0056 , A61K9/006 , A61K9/06 , A61K9/08 , A61K31/56 , A61K31/569 , A61K31/58 , A61K45/06 , A61K47/38 , A61K2300/00
摘要: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
摘要翻译: 本发明涉及口服给药的皮质类固醇组合物。 本发明还提供了治疗与个体中胃肠道炎症有关的病症的方法。 该方法包括向有需要的个体施用本发明的药物组合物。
-